The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: Vote in Parliament, GlaxoSmithKline in focus

Tue, 29th Oct 2019 15:24

(Sharecast News) - The market spotlight on Wednesday will continue to be very much on Brexit, with investors keen to find out what Parliament voted the night before regarding the timing of the upcoming general elections.
But even if the opposition manages to clinch an earlier date than what the government was pushing for, any reaction from traders might be limited ahead of the US central bank's interest rate decision scheduled for after the close of markets.

Fed funds futures have fully priced-in a 25 basis point reduction in the target range for official short-term interest rates from 1.75-2.0% to 1.5-1.75%.

But some economists still se the Federal Reserve holding fire, meaning that there was room for some investors to be left disappointed.

In the background, US consultancy ADP is set to publish its private sector payrolls report for October at 1215 GMT, followed by a preliminary third quarter gross domestic product a quarter of an hour afterwards.

Across the Channel meanwhile, readings are due out on German unemployment in October and surveys of euro area consumer and industrial confidence for the same month.



On the corporate side of things, and for GlaxoSmithKline, analysts at Deutsche Bank were anticipating an approximately 3.0% rise in group sales for the third quarter at constant exchange rates.

Vaccine sales were seen growing by roughly 11.0% CER, helped by sales of Shingrix and early deliveries of its flu vaccines.

Sales at its consumer arm were seen up by 3.0% CER but down by 1.0% on the pharma side of the business.

Margins meanwhile were seen 270 basis points lower year-on-year following its purchase of Tesaro and due to the impact of its CHC joint venture, which combined would result in a 6.0% drop in earnings per share on a CER basis.

Wednesday 30 October

INTERIM DIVIDEND PAYMENT DATE

Essentra, Shore Capital Group Ltd., Smith & Nephew, Trans-Siberian Gold, Xpediator

QUARTERLY PAYMENT DATE

Marble Point Loan Financing Limited NPV

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Business Climate Indicator (EU) (10:00)

Consumer Confidence (EU) (10:00)

Crude Oil Inventories (US) (14:30)

Economic Sentiment Indicator (EU) (10:00)

GDP (Preliminary) (US) (12:30)

Industrial Confidence (EU) (10:00)

MBA Mortgage Applications (US) (11:00)

Services Confidence (EU) (10:00)

Unemployment Rate (GER) (08:55)

Q3

Smurfit Kappa Group

FINALS

Leaf Clean Energy Co (DI)

EGMS

ADES International Holding (DI)

AGMS

Angle, Ashoka India Equity Investment Trust, Frontier Developments, Goldplat, Hargreaves Services, Ideagen, Pantheon International , Redde, Sensyne Health

UK ECONOMIC ANNOUNCEMENTS

BRC Shop Price Index (00:01)

Nationwide House Price Index (07:00)

FINAL DIVIDEND PAYMENT DATE

Haynes Publishing Group

FINAL EX-DIVIDEND DATE

North Atlantic Smaller Companies Inv Trust
More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.